Skip to content
OpenCapital
Get started

Universal Display OLED Net interest and investment income (loss)

Net interest and investment income (loss) at other companies

West Pharmaceutical Services logo
West Pharmaceutical ServicesWST
——

Other financials

Income statement

See full
Revenue$142.2M-14.5%
Gross profit$106.1M-17.2%
Operating income$42.8M-38.6%
Net income$35.9M-44.3%
EPS (diluted)$0.76-43.7%

Balance sheet

See full
Cash & equivalents$159.4M—
Total debt$40.9M—
Total equity$1.7B+2.7%
Total assets$1.9B—

Cash flow

See full
Operating cash flow$108.9M+256%
CapEx$8.6M-34.1%
Free cash flow$100.3M+473%

Valuation

See full
Market cap$4B-34.8%

Profitability

See full
Gross margin75.7%-1.2pp
Operating margin35.4%-2.5pp
Net margin34.1%-1.3pp
FCF margin37.8%+12.6pp

Returns & leverage

See full
Return on equity12.7%-1.9pp
Debt / equity0×—
Current ratio9.5×—

Where this comes from

Reported directly by Universal Display in its filing.

Tagged under the XBRL concept us-gaap:InvestmentIncomeNet.

The official record: Universal Display’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Universal Display's net interest and investment income (loss).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Universal Display's net interest and investment income (loss)?
Universal Display (OLED) reported net interest and investment income (loss) of $8.72M in Q1 2026.
How has Universal Display's net interest and investment income (loss) changed year-over-year?
Universal Display's net interest and investment income (loss) decreased by 13.5% year-over-year, from $10.07M to $8.72M.
What is the long-term trend for Universal Display's net interest and investment income (loss)?
Over 4 years (2021 to 2025), Universal Display's net interest and investment income (loss) has grown at a 197.8% compound annual growth rate (CAGR), from $505K to $39.71M.